Receive monthly emails about the latest oncology research and technology, new patient services, resources and more!

Please select an option below to help us tailor your newsletter to best suit your content interests!

No thanks

Dr. Daniel Vaena Co-Presented Data from Phase I Study at ASCO 2021

Posted by & filed under Uncategorized.

Dr. Daniel Vaena, Director of Experimental Therapeutics Program at West Cancer Center Research Institute, co-presented updated data from Compugen Ltd.’s Phase 1 dose escalation and expansion study of COM701 as a monotherapy, and in a dose escalation combination study with Opdivo® (nivolumab)   Vaena states “Although these results are very preliminary, they suggest that targeting… Read more »

X